Tenax Therapeutics, Inc. (TENX) income statement
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25−0.14 (-10.07%)
Close on Nov 20, 2026Market cap $46.78MP/E –Yield –
Tenax Therapeutics, Inc. financial ratios
See a number that looks wrong?